ABOUT US
Treating tumors quickly, safely and effectively
IceCure Medical is a medical device company founded in 2006 to advance treatment of cancerous tumors. IceCure’s core technology is based on cryoablation, using freezing temperature (liquid nitrogen) to destroy tumors safely, quickly, and painlessly without the need for surgery.
IceCure’s next generation cryoablation technology, the ProSense™ system, enables rapid minimally invasive, safe, and effective treatment of breast lesions in office or ambulatory hospital settings.
The ProSense™ system provides physicians with full control over the procedure, ensuring that the treated zone is destroyed completely while leaving surrounding tissue undamaged.
The ProSense™ system is a proven solution for the treatment of fibroadenomas (benign breast tumors), and is indicated for use in the fields of general surgery, oncology, gynecology, and urology.
IceCure’s team leaders are seasoned medical device and technology entrepreneurs, who have teamed with world-renowned academics, clinical centers, and practitioners to establish advanced cryotherapy as the standard in oncology clinics worldwide.
In October 2018, the American Association of Breast Surgeons adapted its guidelines following the ProSense ICE3 trial, supporting accelerated investigations of cryoablation technology for treatment of malignant breast tumors
Unique technology and powerful IP
27 approved and pending patents
FDA 510(k) cleared, CE marked
For minimally-invasive cryoablation applications
THE TEAM
RON MAYRON
CHAIRMAN OF THE BOARD
Chairman and director of several public and privately owned companies, primarily focusing on the medical device industry. Ron held various senior positions at Teva over the course of 20 years, including CEO Teva Israel and VP Israel & Africa.
EYAL SHAMIR
CEO
Prior to joining IceCure, Eyal served as CEO of medical device and export companies, including B-Cure Laser and Hanita Lenses. Eyal is a seasoned executive and has extensive experience in global business development, particularly China and Japan.
RONEN TSIMERMAN
CFO & COO
Ronen has over 15 years of experience as CFO in public and privately held companies in the medical device and communication infrastructure industries, including C. Mer Telecom Division and Insuline Medical.
TLALIT BUSSI TEL-TZURE
VP BUSINESS DEVELOPMENT & GLOBAL MARKETING
Tlalit has served in senior sales, business development and marketing positions within the healthcare industry for over 18 years, including key roles at DiA Imaging Analysis, Medical Compression Systems, Chemitec, and Trima.
SHAY LEVAV
VP RA/QA & CLINICAL APPLICATIONS
Shay brings nearly 20 years of healthcare management experience in quality assurance and regulatory affairs, previously working for Applied Spectral Imaging, Carestream and Orex (acquired by Kodak).
NAUM MUCHNIK
VP R&D & ENGINEERING
Naum has 15 years of professional experience developing a diverse range of medical device products. He previously served as R&D Mech. Manager at GE Healthcare CardioVascular & POC Ultrasound, and OP&S Manager at Medasense Biometrics.
MERAV NIR DOTAN
VP Human Resources
Merav has over 20 years of experience in human resources and organizational management. She has previously served as VP of Human Resources at Hanita Lenses, and has extensive experience in recruitment and marketing.
GALIT BAR MALIK
VP Operations & Service
Galit has over 16 years of experience in operations and supply chain management in the medical device industry after holding a variety of roles at Mazor Robotics, which was acquired by Medtronic plc.